Av. Cayco et al., RENAL-INSUFFICIENCY AFTER INTRAVENOUS IMMUNE GLOBULIN THERAPY - A REPORT OF 2 CASES AND AN ANALYSIS OF THE LITERATURE, Journal of the American Society of Nephrology, 8(11), 1997, pp. 1788-1794
Over the past decade, intravenous immune globulin therapy (IVIG) has g
ained widespread use for a variety of clinical disorders. IVIG treatme
nt is associated with a number of complications, including acute renal
failure (ARF). Although the cause of IVIG-associated ARF is unknown,
it may be related to the stabilizing agent used in the IVIG preparatio
n. The development and resolution of ARF is typically rapid, but in so
me cases recovery may be delayed and require renal replacement therapy
. In such patients, recurrence of ARF may be avoided by selection of a
preparation with a different stabilizing agent. Two cases of IVIG-ind
uced ARF are described, and all reported cases are analyzed to assess
the probable mechanism of renal injury.